LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesis
= 0.047). LMTK3 expression and subcellular localization evolve during ovarian tumorigenesis. These patterns carry stage-specific prognostic implications, supporting LMTK3 as a spatially resolved biomarker for EOC stratification.
Authors
- Ella Ittner
- Toshima Z. Parris (ORCID: https://orcid.org/0000-0003-0834-5540)
- Khalil Helou (ORCID: https://orcid.org/0000-0002-7847-4391)
- Karin Sundfeldt (ORCID: https://orcid.org/0000-0002-7135-3132)
- Ghassan M. Saed (ORCID: https://orcid.org/0000-0003-1098-7147)
- Per Karlsson (ORCID: https://orcid.org/0000-0003-4841-2672)
- Anikó Kovács
- Lucas Werner
- Hugo Swenson
- Anna Linder
Institutions
- University of Jordan (JO)
- Wayne State University (US)
- Sahlgrenska University Hospital (SE)
- The Barbara Ann Karmanos Cancer Institute (US)
- University of Gothenburg (SE)
Publication Details
- Journal
- Molecular Therapy Oncology
- Published
- 2026-04-06
- DOI
- https://doi.org/10.1016/j.omton.2026.201199
- Primary Topic
- Nuclear Structure and Function
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancerfonden
- Stiftelsen Konung Gustaf V:s Jubileumsfond